[Stent in protected and non-protected left main coronary artery: results and short-term follow-up]

J Farell Campa1, J A Palomo Villada, A Abundes Velasco

  • 1Hospital de Cardiología del Centro Médico Nacional Siglo XXI del Instituto Mexicano del Seguro Social, México, D.F.

Archivos Del Instituto De Cardiologia De Mexico
|June 16, 2000
PubMed

Insights

Left main coronary artery stenting in patients unsuitable for surgery shows promising results. This procedure offers a safe and effective alternative to coronary artery bypass grafting, with high success rates and minimal complications.

Area of Science:

  • Cardiology
  • Interventional Cardiology

Background:

  • Left main coronary artery (LMCA) disease traditionally contraindicates angioplasty due to high risks.
  • Coronary artery bypass grafting (CABG) is the standard treatment, but not always feasible.

Purpose of the Study:

  • To evaluate the safety and efficacy of stenting for LMCA stenoses.
  • To assess outcomes in patients with normal ventricular function who are not surgical candidates.

Main Methods:

  • A retrospective analysis of 10 patients with LMCA stenoses treated with stenting between February 1995 and February 1999.
  • Patients received aspirin and ticlopidine post-procedure.
  • Follow-up included angiography at 3-6 months.

Main Results:

  • 100% procedural success rate with no subacute thrombosis.
  • Only 20% restenosis rate.
  • No deaths occurred during the follow-up period.

Conclusions:

  • Stenting of LMCA stenoses is a safe and effective option for carefully selected patients with normal left ventricular function and prohibitive surgical risks.
  • LMCA angioplasty and/or stenting can be a viable alternative to CABG in this patient group.
  • Larger studies are required to confirm long-term outcomes.
Abstract

Related Concept Videos

Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...